Nicola Wealth Management’s Biogen BIIB Stock Holding History

Nicola Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-39,500	Closed	-$9.16M	–	107
2024 Q2	$9.16M	Hold	39,500	–	–	0.82%	43
2024 Q1	$8.52M	Buy	39,500 +14,500	+58%	+$3.4M	0.83%	40
2023 Q4	$6.47M	Buy	25,000 +3,000	+14%	+$737K	0.68%	46
2023 Q3	$5.65M	Buy	+22,000	New	+$5.88M	0.61%	48

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nicola Wealth Management's BIIB Position: Q3 2024 in Review

Nicola Wealth Management sold out of Biogen (BIIB) in Q3 2024, closing a stake of 39,500 shares — an estimated $9.16M sold.

Nicola Wealth Management first reported a position in BIIB in Q3 2023 and held it in 4 quarters. The position peaked at $9.16M in Q2 2024. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

Nicola Wealth Management reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
Nicola Wealth Management sold 39,500 Biogen shares in Q3 2024, an estimated $9.16M.
Nicola Wealth Management first reported a position in Biogen in Q3 2023 and held it in 4 quarters.
Nicola Wealth Management's Biogen position peaked at $9.16M in Q2 2024.
917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Nicola Wealth Management's 13F filing for Q3 2024, filed 6 Nov 2024.